Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05314868 · ClinicalTrials.gov registry record
Retrospective Evaluation of Photo-oxidized Decellularized Bovine Pericardium in Cardiac Repair or Reconstruction Surgery
A clinical trial, sponsored by Artivion.
- Terminated
- Registry status
- 10
- Enrollment target
NCT05314868 is a clinical trial that was terminated before completion, run by Artivion. The registered enrollment target is 10 participants.
The verdict
NCT05314868 was terminated before completion, sponsored by Artivion.
- TERMINATED
- Registry status
- 10 participants
- Enrollment target
Study Summary
The objective of this postmarket, retrospective, single center study is to evaluate the clinical outcomes of patients who have received PhotoFix® Decellularized Bovine Pericardium (PhotoFix) as a patch within a cardiac surgical repair or reconstruction procedure. PhotoFix is prepared from bovine pericardium, which is stabilized using a dye-mediated photo-oxidation process and sterilized using aseptic processing techniques.
Interventions
- DEVICE PhotoFix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2022-03-31 |
| Est. Completion | 2022-11-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05314868
The ClinicalTrials.gov registry entry for NCT05314868 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Artivion, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PhotoFix is the first listed.
NCT05314868 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05314868 about?
NCT05314868 is a clinical study titled "Retrospective Evaluation of Photo-oxidized Decellularized Bovine Pericardium in Cardiac Repair or Reconstruction Surgery". The objective of this postmarket, retrospective, single center study is to evaluate the clinical outcomes of patients who have received PhotoFix® Decellularized Bovine Pericardium (PhotoFix) as a patch within a cardiac surgical repair or reconstruction procedure. PhotoFix is prepared from bovine per...
What is the current status of trial NCT05314868?
This trial is currently terminated. The enrollment target is 10 participants. The study started on 2022-03-31. Estimated completion is 2022-11-30.
What interventions are being tested in trial NCT05314868?
The interventions under investigation include: PhotoFix (DEVICE).
Who is sponsoring clinical trial NCT05314868?
This trial is sponsored by Artivion, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.